SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-23-028408
Filing Date
2023-06-05
Accepted
2023-06-05 17:08:44
Documents
2
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1472
2 EXHIBIT 24.1 brhc20054060_ex24-1.htm EX-24.1 8404
  Complete submission text file 0001140361-23-028408.txt   11292
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Issuer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451
Business Address
Piekos Brian (Reporting) CIK: 0001815308 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39990 | Film No.: 23993680